---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-057445"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2023-05-09T23:59:59+00:00"
generated_at: "2026-06-15T09:34:51.062280+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Elanco Q1 revenue $1.257B, adj EPS $0.45; raises low end of FY guidance

## Summary
- Q1 revenue $1,257M (+3% reported, +6% CC); includes estimated $90-110M benefit from ERP blackout.
- Adjusted EPS $0.45 (+25% YoY); reported EPS $0.21 vs $0.10 prior year.
- Full year 2023 guidance raised: revenue $4,310-4,400M, adj EPS $0.76-0.83.
- Q2 guidance expects revenue $1,003-1,053M due to ERP blackout pull-forward; adj EPS $0.00-0.05.
- Net leverage 5.4x; received USDA conditional approval for parvovirus antibody, submitted for IL-31 mAb.

## SEC filing metadata
- accession: 0001104659-23-057445
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2023-05-09T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465923057445/0001104659-23-057445-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465923057445/tm2315016d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-057445
- JSON: https://secwatch.observer/filing/0001104659-23-057445.json
- Plain text: https://secwatch.observer/filing/0001104659-23-057445.txt

## Key facts
- Earnings Releases
  Elanco Animal Health Inc reported financial results for the fiscal quarter ended March 31, 2022.
  - Period: the fiscal quarter ended March 31, 2022
  - Result: reported results
  source text: Attached as Exhibit 99.1 and incorporated by reference into this Item 2.02 is a copy of the press release, dated May 9, 2023, announcing the results of operations for the fiscal quarter ended March 31, 2022 and guidance for the full year, first half and second quarter of 2023, for Elanco Animal Health Incorporated.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1739104/000110465923057445/0001104659-23-057445-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.